Pharma AI, IoT & Blockchain

The healthcare (AI) market is to exceed $10 billion by 2024, according to a new report. There will be significant drivers for growth in healthcare AI in the future – such as precision medicine and the need to reduce healthcare costs overall. AI-based medical imaging and diagnosis will see more than 40% growth to more than $2.5 billion by 2024, the report predicted. U.S. healthcare artificial intelligence market was valued over USD 320 million in 2016 and is estimated to witness more than 38% CAGR over the coming years. Drug discovery applications account for over 35% of healthcare artificial intelligence market share, which could see the segment exceed $4 billion in revenue by 2024. Key clinical health AI and machine learning applications can potentially create $150 billion in annual savings for the U.S. healthcare economy by 2026. Revenue in the AI health market is expected to reach $6.6 billion by 2021

The global IoT healthcare market is expected to grow from USD32.4 Bn in 2015 to USD163.2 Bn by 2021, a CAGR of 38.1%. One of the world’s biggest markets for healthcare services, the United States spends approximately 18% of its GDP on healthcare every year. By improving adherence to prescribed therapies alone, the US could significantly reduce their healthcare spends. The effective deployment of IoT-based healthcare delivery technologies could help the US save well over USD 300 billion. Blockchain technology would save the United States pharmaceutical industry over $180 million each year.

This conference will provide insight into the current state of play in the EU & US and stimulate debate, in a multi-stakeholder setting, on the vital role of technology impact in the sustainability of pharma and healthcare systems. Beyond a comprehensive outlook of key European market access policies,  our speakers will outline the key recent developments in technology impact in pharma and healthcare in the EU and other international jurisdictions. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding latest technologies that are being analysed towards the pharma and healthcare. This event will provide an important platform for stakeholders to discuss and share best practices in furthering technology development in pharma and healthcare

It gives me great pleasure in welcoming all of you to the Virtue Insight’s 4th Annual Pharma AI, IoT Blockchain 2021.

KEY THEMES DISCUSSED IN THIS CONFERENCE: –

  • Market overview and analysis – Shaping the future of AI in Pharma
  • ML in Pharma and Medicine – A potential future in which synchronicity of data, analysis, and innovation are an everyday reality
  • Applications of Machine Learning in Pharma and Medicine
  • AI – Challenges and opportunities – Moving forward with a successful strategy
  • Impact of Digital Transformation in healthcare & pharma industry
  • Big data to big impact: AI-driven patient health optimization
  • Big data to big impact: Big data transforming the pharma industry
  • Why Big Pharma  Is Betting on Blockchain
  • How AI technology can accelerate, cheapen, and De-Risk R&D
  • How IoT is transforming the Pharmaceutical Industry?
  • IoT in Pharmaceutical manufacturing and supply chains
  • Big Data Analytics – A Revolution in Drug Discovery and Pharma R&D
  • Differences that Internet of Things (IoT) Can Make to Healthcare
  • How IoT is poised to transform the world of pharma
  • Developing regulatory framework in advanced and developing markets – for Today Tomorrow
  • Moving beyond 5 years – What will the technology landscape look like?
  • Be part of a major virtual networking opportunity,

WHO SHOULD ATTEND: –

CIOs, CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, Evangelists and Senior Scientists from the following areas:

  • Pharmaceuticals
  • Biotech
  • Artificial Intelligence
  • Data Science
  • Machine Learning
  • IoT
  • Cloud
  • Advanced Analytics
  • Innovation
  • Big Data
  • Deep Learning
  • Bioinformatics
  • Regulatory Compliance
  • New Product Development
  • Process Science
  • Portfolio Management
  • Research & Development
  • Business Development
  • Business Operations
  • Scientific Affairs
  • Commercial Affairs
  • Marketing